FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082011 [Registered on: 07/03/2025] Trial Registered Prospectively
Last Modified On: 28/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Evaluate The Shulaghna Effect Of Hingvadi Churna In Udavartini Yonivyapad 
Scientific Title of Study   Randomised Controlled Clinical Trial To Evaluate The Shulaghna Effect Of Hingvadi Churna In The Management Of Udavartini Yonivyapad With Special Reference To Primary Dysmenorrhia  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikita Raju Bisen 
Designation  MS Scholar Streerog and Prasutitantra 
Affiliation  R A Podar Ayurvedic Medical College Worli Mumbai 
Address  Dept Of Streerog And Prasutitantra R A Podar Ayurvedic Medical College Worli Mumbai

Mumbai (Suburban)
MAHARASHTRA
400018
India 
Phone  8208438454  
Fax    
Email  nikitabisen1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrRutuja Gaikwad 
Designation  Assistant professor  
Affiliation  R A Podar Ayurvedic Medical College Worli Mumbai 
Address  Dept Of Streerog And Prasutitantra R A Podar Ayurvedic Medical College Worli Mumbai

Mumbai (Suburban)
MAHARASHTRA
400018
India 
Phone  9699825626  
Fax    
Email  drrutujasg@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRutuja Gaikwad 
Designation  Assistant professor  
Affiliation  R A Podar Ayurvedic Medical College Worli Mumbai 
Address  Dept Of Streerog And Prasutitantra R A Podar Ayurvedic Medical College Worli Mumbai

Mumbai (Suburban)
MAHARASHTRA
400018
India 
Phone  9699825626  
Fax    
Email  drrutujasg@gmail.com  
 
Source of Monetary or Material Support  
OPD NO 8 M.A.Podar Hospital Worli Mumbai 400018 Maharashtra India  
 
Primary Sponsor  
Name  Dr Nikita Raju Bisen 
Address  Dept Of Streerog And Prasutitantra R A Podar Ayurvedic Medical College Worli Mumbai 400018 Maharashtra India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikita Raju Bisen  M A Podar Hospital Worli Mumbai  Department of Gynaecology and Obstetrics first floor Podar Hospital Worli Mumbai 400018 Mumbai MAHARASHTRA
Mumbai (Suburban)
MAHARASHTRA 
8208438454

nikitabisen1@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC R A Podar medical College Worli  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Hingvadi churna, Reference: Bhaishajyaratnavali of shri Govind dasji volume 2, edited by bhisagratna shri bramhashankar Mishra, commentary by shri kaviraja ambikadatta shastri,chaukhamba Sanskrit sansthan, Varanasi,edition:reprint ,2009., Route: Oral, Dosage Form: Churna/ Powder, Dose: 2.5(g), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Lukewarm water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Yavani churna, Reference: Narendra Kumar Meena,Ram Veer Sharma,management of spasmodic (Udavartini Yonivyapada) with Chaturbeeja Churna and Yogic Practices.AYUSHDHARA,2017;4(5):1363-1372., Route: Oral, Dosage Form: Churna/ Powder, Dose: 2.5(g), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -lukewarm water ), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  30.00 Year(s)
Gender  Female 
Details  Patient fulfilling diagnostic criteria patients complaining of pain
during menses with other symptoms of Udavartini Yonivyapada for
at least three consecutive cycles
Patients with age group of 16 to 30 years old.
Married and unmarried patients
Patient with scanty or average flow 
 
ExclusionCriteria 
Details  Patient having irregular menstruation.
Patient having congestive, poly or epi menorrhea
Patient having anatomical and congenital anomalies in genital tract.
Patient with Fibroid, cyst, endometriosis.
Patient suffering from any systemic disease like HTN, DM,
bleeding disorder, cardiac disease, APH, PIH.
Presence of HIV,HbsAg,VDRL,HPV Positive in the patient.
Patient using any IUCDs.
Patient having an endocrinological disorder like Hypothyroidism Hyperthyroidism 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Significantly reduction in pain during menses  2 Consecutive menstrual cycle 
 
Secondary Outcome  
Outcome  TimePoints 
Significantly reduction in pain during menses by using Higvadi churna than Yavani churna   2 Consecutive menstrual cycle 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   25/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
:
Primary objectives- To study the shulaghna effect of Hingvadi Churna in the management of
Udavartini Yonivyapad with special reference to primary dysmenorrhea.
-To find whether Hingvadi churna is more effective than Yavani churna in Udavartini Yonivyapad
Secondary objectives- 
To study the effect of Hingvadi Churna on-
                 Artava praman(menstrual flow)
                 Praseka(nausea)
                 Pain in other region-kati,vankshan,adhoudar shool
                 Aruchi(loss of appetite)
Group A - Hingvadi churna
Group B - Yavani churna
Appropriate Sampling Technique: Simple randomised sampling method by computerised random technique will be done for 76 female patients of age group 18 to 70 years.
The subjects will be randomised in two study groups i.e., Group A and B. The time and date of recruitment shall also be recorded in the enrolment log
Follow up: on 5 th day of menstrual cycle 
Assessment Criteria: The study will be strictly based on assessment of subjective parameter by the grading them.
The data obtained will be analyzed statistically.
Observation and Results: Observation and results will be drawn according to assessment criteria.
Discussion: The observed phenomena will be discussed.
Conclusion: Conclusion will be drawn strictly on basis of statistical analysis and will be unbiased Summary: The research study will be summarized in brief.
Ethical Consideration: The study will be conducted in accordance with ethical guidelines and inform consent from participant.
  
 
Close